The primary efficacy analysis showed the gedatolisib triplet led to statistically significant and clinically meaningful PFS ...

Patient enrollment accelerates across expanding number of clinical trial sites in multiple countries 8 patients enrolled, ...

Dr. Marty Makary, the FDA’s commissioner, said the program targets “dead time,” or about half the time between the launch of ...

Ocugen Inc. (NASDAQ:OCGN) is one of the best biotech penny stocks to buy in 2026. On April 1, Ocugen completed dosing ahead ...

The TAK-881-3001 clinical trial evaluated the PK, efficacy, safety, tolerability and immunogenicity of TAK-881 in adults and pediatric patients aged 2 years and older with PID previously treated with ...

CTA submission positions Silexion for European Phase 2/3 trial of SIL204 in KRAS-driven pancreatic cancer, with Germany ...

Risk Stratification Using Tree-Based Models for Recurrence-Free Survival in Breast Cancer A total of 40.0% of patients received molecular targeted therapy (MTA), including kinase inhibitors and ...

Clinical trials are vital for developing safer, more effective metastatic breast cancer treatments, yet participation is low due to access and financial barriers. Trials progress through phases, from ...

Announcing a new article publication for BIO Integration journal. Clinical trials bridge basic research and clinical application, serving as essential steps in drug development. This review examines ...

Phase 1 clinical trials: These trials test the safety and dose range of a treatment in a small number of healthy volunteers (usually around 20 to 100). A phase 1 trial studies how a medication is ...

Recent Trends and Patient Outcomes of Phase I Trials: A Single-Institution Experience in the Era of New Therapeutic Agents This study reviewed all industry-sponsored phase I clinical trial protocols ...